Dosage & Administration
Adults 1 tablespoonful bid
Children 2 teaspoonful bid
1 tablet 2 to 4 times a day

10 Tablets Blister / bottle
100ml and 200 ml bottles
Each chewable FLO tablet contains powders of:
Yashtimadhu (Glycyrrhiza glabra) 250 mg
Shirish (Albizzia lebbeck) 25 mg
Aantmool (Tylophora asthmatica) 25 mg
Kantkari (Solanum xanthocarpum) 25 mg
Tulsi (Ocimum sanctum) 25 mg
Vasaka (Adhatoda vasaka) 25 mg
Awala (Emblica officinalis) 25 mg
Beheda (Terminalia chebula) 25 mg
Trikatu (P.nigrum, P.longum &
25 mg
Pudina satva (Menthol) 5 mg
Each 5 ml of FLO syrup contains:
Shirish (Albizzia lebbeck) 200 mg
Aantmool (Tylophora indica/asthamatica) 200 mg
Tulsi (Ocimum sanctum) 200 mg
Som (Sarcostemma acidum) 100 mg
Adulsa (Adhatoda vasica) 100 mg
Bharangi (Clerodendron serratum) 100 mg
Vacha (Acorus calamus) 50 mg
Kapur (Camphor) 0.5 mg
Jungli Pyaz (Urginea Indica) 0.5 mg
Peppermint (Menthol) 1 mg
1. Une HD, Pal SC., Kasture VS, Kasture SB. Phytochemistry and Pharmacology of Albizzia lebbeck. Journal of Natural Remedies 2001,1,1-5
2. Amani MD, Mousallamy EL. Leaf flavonoids of Albizia lebbeck. Phytochemistry. 1998;48: 759 - 761
3. Shashidhara S, Bhandarkar A V, Deepak M Comparative evaluation of successive extracts of leaf and stem bark of Albizzia lebbeck for mast cell stabilization activity. Fitoterapia 2008; 79: 301–302
4. C.C. Baruach, P.P. Gupta, G.K. Patnaik, Amarnath, D.K. Kulshreshtha and B.N. Dhawan. Anti anaphylactic and mast cell stabilizing activity of Albizzia lebbeck. Ind Vet Med Jour. 1997; 21(2): 127-32.
5. C.C. Baruah, P.P. Gupta, G.K. Patnaik, S.Bhattacharya, R.K. Goel, D.K. Kulshreshtha, M.P. Dubey and B.N. Dhawan, Immunomodulatory effect of Albizzia Lebbeck, Pharmaceutical Biology, 2000; 38(3): 161-6.
6. C.C. Baruah, P.P. Gupta, G.K. Patnaik, M.P. Dubey, R.K. Goel and B.N. Dhawan. Comparative study of the anti-PCA and mast-cell stabilizing activity fractions of Albizzia Lebbeck: a traditional medicinal plant, Journal of Medicinal and Aromatic plants sciences, 2000; 22: 42.
7. Tripathi R M and Das P K. Studies on Anti-Asthmatic and Anti-Anaphylactic Activity of Albizzia lebbeck Ind. J. Pharmac. 1977; 9 (3):189-194
8. Ali M and Bhutani K K. Investigation of Medicinal-Plants 11. Alkaloids from Tylophora indica. Phytochemistry. 1989; 28: 3513–3517.
9. Ganguly T and Sainis K B. Inhibition of cellular immune responses by Tylophora indica in experimental models. Phytomedicine. 2001; 8: 348–355.
10. Udupa A L, Udupa S L and Guruswamy M N. The possible site of anti-asthmatic action of Tylophora asthmatica on pituitary-adrenal axis in albino rats. Planta Med. 1991; 57: 409–413.
11. Gore, K.V., Rao, A.K., and Guruswamy, M.N. Physiological studies with Tylophora asthmatica in bronchial asthma. Indian J Med Res 1980; 71: 144–148.
12. Claeson, U.P. et al. Adhatoda vasica: a critical review of ethnopharmacological and toxicological data. J Ethnopharmacol. 2000; 72: 1–20.
13. Dhuley J N.Antitussive effect of Adhatoda vasica extract on mechanical or chemical stimulation-induced coughing in animals. Journal of Ethnopharmacology 1999; 67: 361–365
14. Cambridge, G.W., Jansen, A.B., and Jarman, D.A. Bronchodilating action of vasicinone and related compounds. Nature. 1962; 196: 1217.
15. Gupta, O.P. and et al. Pharmacological investigations of vasicine and vasicinone-the alkaloids of Adhatoda vasica. Indian J Med Res. 1977 66: 690–691.
16. Sirkar NN. Pharmacological basis of Ayurvedic therapeutics. In: Cultivation and utilization of medicinal plants. Editors: Atal CK and Kapoor BM (Published by CSIR) 1989.
17. Prakash P & Gupta N.therapeutic uses of ocimum sanctum linn (tulsi) with a note on eugenol and its pharmacological actions: A short review Indian J Physiol Pharmacol 2005; 49 (2) : 125–131
18. Pratibha D. Nadig & Laxmi S. Study of anti-tussive activity of Ocimum sanctum Linn in guinea pigs Indian J Physiol Pharmacol 2005; 49 (2): 243–245
19. Saraf M N, Patwardhan B K. Pharmacological studies on Sarcostemma brevistigma. Part II Bronchodilator activity. Ind. Drugs. 1988; 26: 54-57.
20. Narayanan N, Thirugnanasambantham P, Viswanathan S, Vijayasekaran V, Sukumar E. Antinociceptive, anti-inflammatory and antipyretic effects of ethanol extract of Clerodendron serratum roots in experimental animals. Journal of Ethnopharmacology 1999; 65, 237-241
21. Yende SR et al. Pharmacological profile of Acorus calamus: An Overview. Pharmacognosy Reviews, 2008; 2(4): 22-26
22. Rai R and Nath V. Use of medicinal plants by traditional herbal healers in Central India XII World forestry Congress, Quebec City, Canada
23. P.S. Vaidyaratnam, Varier’s Indian medicinal plants. (Oriental Longman Ltd, Arya Vaidya Sala, Kottakal, 1994, pp.51
24. Kitagawa, I., Chen, W. Z., Hori, K., Harada, E., Yasuda, N., Yoshikawa, M., and Ren, J. Chemical studies of Chinese licorice-roots. I. Elucidation of five new flavonoid constituents from the roots of Glycyrrhiza glabra L. collected in Xinjiang. Chem Pharm Bull (Tokyo) 1994; 42(5):1056-1062
25. Baker, M. E. and Fanestil, D. D. Licorice, computer-based analyses of dehydrogenase sequences, and the regulation of steroid and prostaglandin action. Mol Cell Endocrinol. 1991; 78(1-2):C99-102.
26. Vadnere G P et al. Evaluation of anti-asthmatic property of Solanum xanthocarpum flower extracts. Pharmacologyonline 2008, 1: 513-522
27. Gupta, S.S. and Gupta, M.K. Effect of Solanum xanthocarpum and Clerodendron serratum on histamine release from tissues. Indian J. Med.Sci. 1967; 21: 795-799
28. Govindan S, Viswanathan S, Vijayasekaran V, Alagappan R. A pilot study on the clinical efficacy of S. xanthocarpum and S. trilobatum in bronchial asthma. J Ethnopharmacol 1999; 66: 205–210.
29. Govindan S, Viswanathan S, Vijayasekaran V, Alagappan R. Further Studies on the Clinical Efficacy of Solanum xanthocarpum and Solanum trilobatum in Bronchial Asthma. Phytother. 2004, Res. 18, 805–809
30. L. Sugana, S. Singh, P. Shivakumar, P. Sampath, G. Chandrakasan. Influence of Terminalia chebula on dermal wound healing in rats. Phytother Res., 2002; 16(3) : 227-31.
31. A.K. Nadkarni. Terminalia chebula In : Dr. K.M. Nadkarni’s Indian Materia Madica, 3rd Edn. (Popular Prakashan Pvt. Ltd., Bombay, 1976), pp. 1202-11.
32. Nosalova G. Mokry J. Tareq Hassan KM. Antitussive activity of the fruit extract of Emblica officinalis Gaertn. (Euphorbiaceae) Phytomedicine 2003; 10(6, 7):583-589.
33. Anshuman P S, Singh K P, & Aasra K G. Effect of Vardhman Pippali (Piper longum) on patients with respiratory disorders. Sachitra Ayurved, 1984; 37 (1): 47-49.
34. Dhanukar S A, & Karandikar S M. Evaluation of anti-allergic activity of Piper longum. Indian Drugs. 1984; 21 (9): 377-383.
35. Dhanukar S A. Karandikar S M, & Desai M. Efficacy of Piper longum in childhood asthma, Indian Drugs. 1984; 21(9): 384-388.
36. Fernandes A, Taraves F, & Athavale V B. Asthma in children: A clinical controlled study of Piper longum in asthma. Paediatr. Clin. India, 1980; 15(4): 45.
37. Lee SW et al Alkamides from the fruits of Piper longum and Piper nigrum displaying potent cell adhesion inhibition. Bioorg Med Chem Lett. 2008; 15; 18(16):4544-6.
38. Hirata N et al. Histamine release inhibitory activity of Piper nigrum leaf. Biol Pharm Bull. 2008; 31(10):1973-6.
39. Dedov VN, Tran VH, Duke CC, Connor M, Christie MJ, Mandadi S, et al. Gingerols: a novel class of vanilloid receptor (VR1) agonists. Br J Pharmacol 2002;137:793–8
40. Grzanna R, Lindmark L, Frondoza CG. Ginger—an herbal medicinal product with broad anti-inflammatory actions. J Med Food. 2005; 8: 125-32.
41. Shen CL, Hong KJ, Kim SW. Comparative effects of ginger root (Zingiber officinale Rosc.) on the production of inflammatory mediators in normal and osteoarthrotic sow chondrocytes. J Med Food 2005; 8: 149–53.
42. M.L.B. Ahui et al. Ginger prevents Th2-mediated immune responses in a mouse model of airway inflammation International Immunopharmacolog
Explore Product
Flo - Chewable Tablets Syrup
Therapeutic Category : Bronchodilatory Mucolytic Expectorant
The multiple herbs in FLO collectively act to control and restore the inflamed congested muco-respiratory environment. The major actions include:
  • Potent mucolytic and expectorant activity due to vasicinine from Adulsa, saponins from Bharangi and volatile oils from Menthol and Camphor
  • Soothing demulcent activity due to asarones from Vacha and saponins from Bharangi.
  • Mild bronchodilatory activity due to presence of alantoids from Pushkarmool and alkaloids from Aantmool.
  • Bronchial mast cells stabilising action preventing release of the inflammatory mediators onto the respiratory surface due to quercitin from Jungli pyaz, saponins from Shirish and alkaloids from Aantmool.
  • Inducing increased secretion of the endogenous corticosteroids thereby controlling the bronchial inflammatory chain reaction. This action is due to a direct effect of alkaloids from Aantmool on the adrenal cortex and is responsible for the prolonged beneficial effects seen in asthmatics
  • Cough of varied etiologies
  • Bronchial asthma (Tamaka svasa)
  • Bronchial congestion
  • Emphysema (Svasa)
  • Laryngitis (Galaugha)
  • Sinusitis (Pinasa)
  • Sore throat (Kantha roga)